The weirdest GLP-1 side effect yet? The bizarre way weight loss drugs are messing with people’s hearing
GLP-1 weight loss drugs, while effective, are linked to a rare ear condition known as patulous Eustachian tube dysfunction (pETD). Patients like Sarah Ago have reported experiencing overwhelming sounds of their own voice and breathing after rapid weight loss. Doctors are seeing an increase in pETD cases among those using these medications, highlighting a lesser-known side effect of GLP-1 treatments.
- ▪GLP-1 drugs have helped many lose weight and manage diabetes but come with risks.
- ▪Sarah Ago experienced pETD after losing over 60 pounds on GLP-1s, causing her to hear her own voice at an amplified volume.
- ▪Doctors are reporting a rise in pETD cases linked to rapid weight loss from GLP-1 medications.
New York Post files mainly under news. We currently carry 11,003 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | New York Post |
| Canonical URL | https://nypost.com/2026/05/27/health/glp-1s-are-fueling-a-rise-of-a-bizarre-rare-ear-disorder/ |
| Publication time | Wed, 27 May 2026 07:44:00 -0400 |
| Retrieval time | 2026-05-27T11:47:58.933Z |
| Last seen | 2026-05-27T11:47:58.933Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | 10qrgUtLK7Wz |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Health exclusive The Thin Line The weirdest GLP-1 side effect yet? The bizarre way weight loss drugs are messing with people’s hearing By McKenzie Beard Published May 27, 2026, 7:44 a.m. ET See more of our coverage in your search results. Add The New York Post on Google Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage diabetes and improve other health conditions, they are not without risks. Check back for more stories about the lesser-known downsides of these wildly popular medications. The day Sarah Ago buried her mother, grief should have been the hardest thing she had to contend with.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at New York Post.
Discussion
0 commentsMore from New York Post
